Charles W. Newhall III, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 1,412 shares at $45.00 ($64K) on 2025-08-22, disclosed to the SEC on 2025-08-26.
Scheduled sale ($64k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SUPN | SELL | 2025-08-27 | $45K | — | Filing → |
| SUPN | SELL | 2024-11-12 | $388K | — | Filing → |
| SUPN | SELL | 2023-11-20 | $70K | — | Filing → |